BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32883024)

  • 1. Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling.
    Lee JS; Lee H; Jang H; Woo SM; Park JB; Lee SH; Kang JH; Kim HY; Song J; Kim SY
    Cells; 2020 Sep; 9(9):. PubMed ID: 32883024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of bioenergetics through dual inhibition of aldehyde dehydrogenase and mitochondrial complex I suppresses glioblastoma tumorspheres.
    Park J; Shim JK; Kang JH; Choi J; Chang JH; Kim SY; Kang SG
    Neuro Oncol; 2018 Jun; 20(7):954-965. PubMed ID: 29294080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Mitochondrial Oxidative Phosphorylation Abrogated Irinotecan Resistance in NSCLC.
    Lee S; Lee JS; Seo J; Lee SH; Kang JH; Song J; Kim SY
    Sci Rep; 2018 Oct; 8(1):15707. PubMed ID: 30356107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.
    Kang JH; Lee SH; Lee JS; Nam B; Seong TW; Son J; Jang H; Hong KM; Lee C; Kim SY
    Oncotarget; 2016 Aug; 7(31):49397-49410. PubMed ID: 27384481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer.
    Masoud R; Reyes-Castellanos G; Lac S; Garcia J; Dou S; Shintu L; Abdel Hadi N; Gicquel T; El Kaoutari A; Diémé B; Tranchida F; Cormareche L; Borge L; Gayet O; Pasquier E; Dusetti N; Iovanna J; Carrier A
    Cell Rep Med; 2020 Nov; 1(8):100143. PubMed ID: 33294863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance Is Futile: Targeting Mitochondrial Energetics and Metabolism to Overcome Drug Resistance in Cancer Treatment.
    Bosc C; Selak MA; Sarry JE
    Cell Metab; 2017 Nov; 26(5):705-707. PubMed ID: 29117545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial Therapeutic Effect of Inhibitors of Aldehyde Dehydrogenase and Mitochondrial Complex I, and the Chemotherapeutic Drug, Temozolomide against Glioblastoma Tumorspheres.
    Park HH; Park J; Cho HJ; Shim JK; Moon JH; Kim EH; Chang JH; Kim SY; Kang SG
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33429981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel inhibitor of the mitochondrial respiratory complex I with uncoupling properties exerts potent antitumor activity.
    Al Assi A; Posty S; Lamarche F; Chebel A; Guitton J; Cottet-Rousselle C; Prudent R; Lafanechère L; Giraud S; Dallemagne P; Suzanne P; Verney A; Genestier L; Castets M; Fontaine E; Billaud M; Cordier-Bussat M
    Cell Death Dis; 2024 May; 15(5):311. PubMed ID: 38697987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual inhibition of oxidative phosphorylation and glycolysis to enhance cancer therapy.
    Sheng X; Wang MM; Zhang GD; Su Y; Fang HB; Yu ZH; Su Z
    Bioorg Chem; 2024 Jun; 147():107325. PubMed ID: 38583247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.
    Yu L; Gu C; Zhong D; Shi L; Kong Y; Zhou Z; Liu S
    Cancer Lett; 2014 Dec; 355(1):34-45. PubMed ID: 25236911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
    Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
    Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canagliflozin inhibits p-gp function and early autophagy and improves the sensitivity to the antitumor effect of doxorubicin.
    Zhong J; Sun P; Xu N; Liao M; Xu C; Ding Y; Cai J; Zhang Y; Xie W
    Biochem Pharmacol; 2020 May; 175():113856. PubMed ID: 32061772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
    Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
    Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria Targeting as an Effective Strategy for Cancer Therapy.
    Ghosh P; Vidal C; Dey S; Zhang L
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinated autophagy modulation overcomes glioblastoma chemoresistance through disruption of mitochondrial bioenergetics.
    Kriel J; Müller-Nedebock K; Maarman G; Mbizana S; Ojuka E; Klumperman B; Loos B
    Sci Rep; 2018 Jul; 8(1):10348. PubMed ID: 29985441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugging OXPHOS Dependency in Cancer.
    Cancer Discov; 2019 Aug; 9(8):OF10. PubMed ID: 31186236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.
    Denise C; Paoli P; Calvani M; Taddei ML; Giannoni E; Kopetz S; Kazmi SM; Pia MM; Pettazzoni P; Sacco E; Caselli A; Vanoni M; Landriscina M; Cirri P; Chiarugi P
    Oncotarget; 2015 Dec; 6(39):41706-21. PubMed ID: 26527315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment.
    Sui X; Chen R; Wang Z; Huang Z; Kong N; Zhang M; Han W; Lou F; Yang J; Zhang Q; Wang X; He C; Pan H
    Cell Death Dis; 2013 Oct; 4(10):e838. PubMed ID: 24113172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyethylene glycol derivative 9bw suppresses growth of neuroblastoma cells by inhibiting oxidative phosphorylation.
    Nagasaki-Maeoka E; Ikeda K; Takayama KI; Hirano T; Ishizuka Y; Koshinaga T; Tsukune N; Takayama T; Inoue S; Fujiwara K
    Cancer Sci; 2020 Aug; 111(8):2943-2953. PubMed ID: 32495467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer.
    Totten SP; Im YK; Cepeda Cañedo E; Najyb O; Nguyen A; Hébert S; Ahn R; Lewis K; Lebeau B; La Selva R; Sabourin V; Martínez C; Savage P; Kuasne H; Avizonis D; Santos Martínez N; Chabot C; Aguilar-Mahecha A; Goulet ML; Dankner M; Witcher M; Petrecca K; Basik M; Pollak M; Topisirovic I; Lin R; Siegel PM; Kleinman CL; Park M; St-Pierre J; Ursini-Siegel J
    Nat Commun; 2021 Jun; 12(1):3299. PubMed ID: 34083537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.